CYTENA

cytena GmbH has developed a device called cy-Clone to separate single cells. Single cells are required for the development of state-of-the-art drugs, so-called biologicals as well as for the genetic analysis of single cells for cancer and stem cell research. The cy-Clone is supported by an automated imaging process to encapsulate cells in droplets, which are delivered to any type of substrate. Thanks to this particularly gentle delivery method, the cells are able to survive post printing and can either be analyzed thereafter or grown into clonal colonies. To determine clonality, multiple images are recorded during the process. Cross-contamination is avoided by the use of disposable parts.

#People #Financial #Event #Website #More

CYTENA

Social Links:

Twitter

Industry:

Biotechnology Genetics Health Care Medical

Founded:

2014-06-01

Address:

Freiburg, Baden-Wurttemberg, Germany

Country:

Germany

Website Url:

http://www.cytena.com

Total Employee:

11+

Status:

Closed

Contact:

+004976120373260

Email Addresses:

[email protected]

Total Funding:

4.1 M EUR

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Global Site Tag Mobile Non Scaleable Content